IndraLab
Statements
reach
"Studies of post-myocardial infarction myocardial fibrosis revealed that OTU deubiquitinase 4 upregulated PFKFB3 to promote post-myocardial infarction cardiac fibrosis and that the inhibition of PFKFB3 helps ameliorate ischemia-induced cardiac fibrosis; therefore, the use of PFKFB3 inhibitors may provide a new therapeutic option for the treatment of post-myocardial infarction cardiac fibrosis (125)."